Back to search

Article

SGLT2 inhibition attenuates γδ T cell–mediated meta-inflammation associated with cardiometabolic risk in type 2 diabetes

2026-03-13

Abstract excerpt

<title>Abstract</title> <p> <bold>Background</bold> Cardiovascular and renal protection conferred by sodium–glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) extends beyond glucose lowering. Chronic low-grade meta-inflammation is a key driver of cardiometabolic risk in type 2 diabetes (T2D), yet the cellular mediators modified by modern antidiabetic therapy rema...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ba3121ee-37cf-5e16-8b5a-7fc31935d261
DOI
10.21203/rs.3.rs-9020037/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SGLT2 inhibition attenuates γδ T cell–mediated meta-inflammation associated with cardiometabolic risk in type 2 diabetesDOI 10.21203/rs.3.rs-9020037/v1
Select a neighboring publication to make it the new centre.